CN101253990A - Soft capsules improving memory function - Google Patents
Soft capsules improving memory function Download PDFInfo
- Publication number
- CN101253990A CN101253990A CN200810103633.XA CN200810103633A CN101253990A CN 101253990 A CN101253990 A CN 101253990A CN 200810103633 A CN200810103633 A CN 200810103633A CN 101253990 A CN101253990 A CN 101253990A
- Authority
- CN
- China
- Prior art keywords
- soft capsule
- vitamin
- memory function
- oil
- epa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007901 soft capsule Substances 0.000 title claims abstract description 29
- 230000006386 memory function Effects 0.000 title claims abstract description 17
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 34
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 34
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims abstract description 17
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 17
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 17
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 17
- 235000019152 folic acid Nutrition 0.000 claims abstract description 17
- 239000011724 folic acid Substances 0.000 claims abstract description 17
- 229960000304 folic acid Drugs 0.000 claims abstract description 17
- 229960003080 taurine Drugs 0.000 claims abstract description 17
- 239000011710 vitamin D Substances 0.000 claims abstract description 17
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 17
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 17
- 229940046008 vitamin d Drugs 0.000 claims abstract description 17
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 14
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 14
- 239000011719 vitamin A Substances 0.000 claims abstract description 14
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 14
- 229940045997 vitamin a Drugs 0.000 claims abstract description 14
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 12
- 239000008158 vegetable oil Substances 0.000 claims abstract description 12
- 239000000084 colloidal system Substances 0.000 claims abstract description 8
- 238000005498 polishing Methods 0.000 claims abstract description 8
- 239000003381 stabilizer Substances 0.000 claims abstract description 5
- 239000000375 suspending agent Substances 0.000 claims abstract description 5
- 229940083466 soybean lecithin Drugs 0.000 claims description 16
- 239000001856 Ethyl cellulose Substances 0.000 claims description 14
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 14
- 235000013871 bee wax Nutrition 0.000 claims description 14
- 239000012166 beeswax Substances 0.000 claims description 14
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 14
- 229920001249 ethyl cellulose Polymers 0.000 claims description 14
- 230000036541 health Effects 0.000 claims description 13
- 235000013376 functional food Nutrition 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 238000007872 degassing Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 235000019483 Peanut oil Nutrition 0.000 claims description 5
- 239000000312 peanut oil Substances 0.000 claims description 5
- 239000003549 soybean oil Substances 0.000 claims description 5
- 235000012424 soybean oil Nutrition 0.000 claims description 5
- 235000019498 Walnut oil Nutrition 0.000 claims description 4
- 239000004006 olive oil Substances 0.000 claims description 4
- 235000008390 olive oil Nutrition 0.000 claims description 4
- 239000008170 walnut oil Substances 0.000 claims description 4
- 239000010620 bay oil Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 7
- 238000005516 engineering process Methods 0.000 abstract description 3
- 230000004438 eyesight Effects 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 235000001497 healthy food Nutrition 0.000 abstract 1
- 239000011259 mixed solution Substances 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000008347 soybean phospholipid Substances 0.000 abstract 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 23
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 8
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 244000037364 Cinnamomum aromaticum Species 0.000 description 3
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 3
- 239000003610 charcoal Substances 0.000 description 3
- 229960004488 linolenic acid Drugs 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 201000005671 spondyloarthropathy Diseases 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a soft capsule for improving memory function, and belongs to the technology field of functional healthy food. The invention has the method that DHA, EPA, soybean phospholipid, taurine, folic acid, vitamin A, and vitamin D are weighted and added in vegetable oil for dissolving, and stabilizing agent and suspending agent are then added in; the solution is mixed uniformed by a spiral mixer; the mixed solution which passes through a colloid mill is processed through desaeration, pelleting, finalization dryness, disk-arraying dryness, pill selection, and polishing, so as to make the product. The soft capsule contains a plurality of efficacies and ingredients, and more particularly the content of polyunsaturated fatty acid is high; the product has multiple healthcare functions of improving the memory, enhancing the vision, lowering the blood-fat, lowering the blood pressure, resisting the oxidation, increasing the immunity, etc. The product has reasonable prescription, advanced process, small dosage, convenient medicine-taking, high bioavailability, stable active ingredient, direct action, quick result, and definite curative effect. Good healthcare effect can be achieved by adopting the soft capsule for a long time.
Description
Technical field
The present invention relates to a kind of health functional food, relate in particular to a kind of memory function capsule health food containing that improves, belong to the health functional food technical field.
Background technology
It is generally acknowledged the forgetful organic forgetful and functional forgetful two big classes that are divided into.Organic forgetful be that organic disease or wound reason owing to health causes.Comprise brain tumor, brain trauma, encephalitis, cerebral apoplexy etc., cause failure of memory or forfeiture; Some chronic disease as endocrine dysfunction, malnutrition, slow poisoning, artery sclerosis, cervical spondylopathy etc., also can be damaged brain and cause forgetful.Functional forgetfully mainly show: the decrease of memory that age growth causes; The decrease of memory that the hobby tobacco and wine cause; Life, the big initiation psychological problems of operating pressure cause decrease of memory; Take in subalimentation and cause decrease of memory.Mostly children's decrease of memory is because pressure and nutrition cause.
The present invention overcomes the prior art deficiency, and a kind of memory function capsule health food containing that improves is provided.
Summary of the invention
One of the object of the invention provides a kind of memory function capsule health food containing that improves; Two of the object of the invention provides a kind of preparation method who improves the memory function capsule health food containing.
A kind of memory function soft capsule that improves of the present invention is that primary raw material is made with DHA (22 charcoal acid), EPA (20 charcoal pentaene acid), soybean lecithin, taurine, folic acid, vitamin A, vitamin D and vegetable oil; have the memory function of improvement, also have and reduce blood fat, the effect that brings high blood pressure down, vision protection, health care such as anti-oxidant.
The present invention realizes like this; take by weighing DHA, EPA, soybean lecithin, taurine, folic acid, vitamin A, vitamin D by prescription and add in 60～80 ℃ the vegetable oil and dissolve, add stabilizing agent, suspending agent again, fully mix with helical mixer; cross colloid mill; the degassing, pelleting, typing is dry; row is coiled drying; select ball, polishing makes soft capsule health functional food of the present invention.
Soft capsule formula for a product of the present invention is; DHA10～150g; EPA 10～150g; soybean lecithin 10～50g, taurine 1～20g, folic acid 1～100mg, vitamin A 1～200mg, vitamin D 1～200mg, beeswax 20～60g;, ethyl cellulose 5～50g; all the other are vegetable oil, and gross weight 1000g makes 2000 of the soft capsules of 0.5g/ grain.
Vegetable oil of the present invention is any one or a few a miscella in soybean oil, peanut oil, olive oil, walnut oil, bay-oil, the siritch.
Stabilizing agent of the present invention, suspending agent are beeswax and ethyl cellulose.
DHA promptly is 22 charcoal acids, and EPA promptly is an eicosapentaenoic acid, and they are polyunsaturated fatty acids of just being found by scientist in recent years, and these materials have very big benefit to health.The source is an alpha-linolenic acid in the body of EPA, DHA.After alpha-linolenic acid entered human body, under the effect with a kind of desaturase, deriving in human body was EPA and DHA, and alpha-linolenic acid and EPA and DHA all belong to omega-fatty acid.Many scientists studies have shown that: ω-3 is of value to prevention and treatment coronary heart disease, diabetes, rheumatoid disease, dermatitis, cancer, depression, psychotic disorder, dementia, allergy, asthma, ephrosis and chronic obstructive pulmonary disease etc.The physiological function of EPA and DHA mainly contain following some: EPA has the effect of cholesterol and content of triglyceride in anti-inflammatory, anti-arrhythmia, adjusting blood fat and the blood, softening blood vessel, can prevent the cardiovascular and cerebrovascular disease that is caused by artery sclerosis.DHA can improve memory, has brain strengthening function, improves memory, judgment.The systematic growth of brain optic nerve be can promote, brain and photosensory cell vigor strengthened.When EPA and DHA enter cell membrane, can prevent platelet aggregation, reduce blood fat, and then reduce blood viscosity, improve blood fluidity, reduce the danger of thrombus.EPA and DHA can reduce blood cholesterol levels content, prevention coronary heart disease.EPA and DHA can prevent and suppress cancer.
The present invention contains the multiple efficacies composition, content of polyunsaturated fatty acid height especially, product of the present invention have the memory of improvement, promote intelligence, improve eyesight, reduce blood fat, bring high blood pressure down, anti-oxidant, improve plurality of health care functions such as immunity.Formula for a product of the present invention is reasonable, technology is advanced, and dose is little, taking convenience, the bioavilability height, stable effective ingredients, the effect direct, rapid-action, exact efficacy.Long-term edible soft capsule of the present invention can reach good health-care effect.
Choose 100 the elderlys in Beijing area as study subject, the experimenter just is divided into balanced two groups by memory quotient, every group 50 people selects one group to be that test group is taken product of the present invention at random, and 60d is taken in contact, every day 3 times, each 2, detect with the Clinical Memory table, found that, test back test group memory quotient average out to 89.6 is significantly improved than taking preceding 78.3.Find that simultaneously part the elderly high fat of blood, hypertension symptom have tangible alleviation.
The specific embodiment
The following examples help those skilled in the art more fully to understand the present invention, but do not limit the present invention in any way.
Embodiment 1
Taking by weighing DHA, EPA, soybean lecithin, taurine, folic acid, vitamin A, vitamin D by prescription adds in 60～80 ℃ the vegetable oil and dissolves; add beeswax, ethyl cellulose again; fully mix with helical mixer, cross colloid mill, the degassing; pelleting; typing is dry, and row is coiled drying, selects ball; polishing makes soft capsule health functional food of the present invention.
Formula for a product is; DHA10～150g; EPA 10～150g; soybean lecithin 10～50g, taurine 1～20g, folic acid 1～100mg, vitamin A 1～200mg, vitamin D 1～200mg, beeswax 20～60g;, ethyl cellulose 5～50g; all the other are vegetable oil, and gross weight 1000g makes 2000 of the soft capsules of 0.5g/ grain.
Embodiment 2
Taking by weighing DHA, EPA, soybean lecithin, taurine, folic acid, vitamin A, vitamin D by prescription adds in 65 ℃ the soybean oil and dissolves; add beeswax, ethyl cellulose again; fully mix with helical mixer, cross colloid mill, the degassing; pelleting; typing is dry, and row is coiled drying, selects ball; polishing makes soft capsule health functional food of the present invention.
Formula for a product is DHA 100g, EPA 50g; soybean lecithin 50g, taurine 20g, folic acid 100mg, vitamin A 10mg, vitamin D 20mg, beeswax 20g,, ethyl cellulose 50g, all the other are soybean oil; gross weight 1000g makes 2000 of the soft capsules of 0.5g/ grain.
Embodiment 3
Taking by weighing DHA, EPA, soybean lecithin, taurine, folic acid, vitamin A, vitamin D by prescription adds in 75 ℃ peanut oil and the cassia oil miscella and dissolves; add beeswax, ethyl cellulose again; fully mix with helical mixer, cross colloid mill, the degassing; pelleting; typing is dry, and row is coiled drying, selects ball; polishing makes soft capsule health functional food of the present invention.
Formula for a product is; DHA 50g; EPA 100g; soybean lecithin 10g, taurine 10g, folic acid 10mg, vitamin A 100mg, vitamin D 150mg, beeswax 40g;, ethyl cellulose 10g, all the other are peanut oil and cassia oil, peanut oil and cassia oil ratio are 5: 3; gross weight 1000g makes 2000 of the soft capsules of 0.5g/ grain.
Embodiment 4
Taking by weighing DHA, EPA, soybean lecithin, taurine, folic acid, vitamin A, vitamin D by prescription adds in 75 ℃ the soybean oil and dissolves; add beeswax, ethyl cellulose again; fully mix with helical mixer, cross colloid mill, the degassing; pelleting; typing is dry, and row is coiled drying, selects ball; polishing makes soft capsule health functional food of the present invention.
Formula for a product is; DHA 120g; EPA 60g; soybean lecithin 20g, taurine 15g, folic acid 60mg, vitamin A 120mg, vitamin D 10mg, beeswax 50g;, ethyl cellulose 20g, all the other are siritch and olive oil, siritch and olive oil ratio are 7: 3; gross weight 1000g makes 2000 of the soft capsules of 0.5g/ grain.
Embodiment 5
Taking by weighing DHA, EPA, soybean lecithin, taurine, folic acid, vitamin A, vitamin D by prescription adds in 75 ℃ the walnut oil and dissolves; add beeswax, ethyl cellulose again; fully mix with helical mixer, cross colloid mill, the degassing; pelleting; typing is dry, and row is coiled drying, selects ball; polishing makes soft capsule health functional food of the present invention.
Formula for a product is DHA 120g, EPA 60g; soybean lecithin 20g, taurine 15g, folic acid 60mg, vitamin A 120mg, vitamin D 10mg, beeswax 50g,, ethyl cellulose 20g, all the other are walnut oil; gross weight 1000g makes 2000 of the soft capsules of 0.5g/ grain.
Claims (6)
1. one kind is improved the memory function soft capsule; with DHA, EPA, soybean lecithin, taurine, folic acid, vitamin A, vitamin D and vegetable oil is that primary raw material is made; it is characterized in that; taking by weighing DHA, EPA, soybean lecithin, taurine, folic acid, vitamin A, vitamin D by prescription adds in the vegetable oil and dissolves; add stabilizing agent, suspending agent again; fully mix with helical mixer; cross colloid mill; the degassing, pelleting, typing is dry; row is coiled drying; select ball, polishing makes soft capsule health functional food of the present invention.
2. a kind of memory function soft capsule that improves according to claim 1; it is characterized in that; described a kind of memory function soft capsule formula for a product of improving is; DHA10～150g; EPA 10～150g, soybean lecithin 10～50g, taurine 1～20g, folic acid 1～100mg, vitamin A 1～200mg, vitamin D 1～200mg, beeswax 20～60g,, ethyl cellulose 5～50g; all the other are vegetable oil, gross weight 1000g.
3. a kind of memory function soft capsule that improves according to claim 1 and 2 is characterized in that, described vegetable oil is any one or a few a miscella in soybean oil, peanut oil, olive oil, walnut oil, bay-oil, the siritch.
4. a kind of memory function soft capsule that improves according to claim 1 and 2 is characterized in that 60～80 ℃ of described vegetable oil temperature.
5. a kind of memory function soft capsule that improves according to claim 1 is characterized in that described stabilizing agent, suspending agent are beeswax and ethyl cellulose.
6. a kind of memory function soft capsule that improves according to claim 1 is characterized in that, described a kind of memory function soft capsule product that improves is the 0.5g/ grain.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810103633.XA CN101253990A (en) | 2008-04-09 | 2008-04-09 | Soft capsules improving memory function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810103633.XA CN101253990A (en) | 2008-04-09 | 2008-04-09 | Soft capsules improving memory function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101253990A true CN101253990A (en) | 2008-09-03 |
Family
ID=39889379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200810103633.XA Pending CN101253990A (en) | 2008-04-09 | 2008-04-09 | Soft capsules improving memory function |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101253990A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101618029B (en) * | 2009-07-19 | 2011-10-26 | 广东长兴科技保健品有限公司 | Soft capsule with function of improving memory and preparation technology thereof |
| CN101485445B (en) * | 2009-02-23 | 2012-09-26 | 梁德昌 | Health care food |
| CN102919842A (en) * | 2012-11-14 | 2013-02-13 | 汾州裕源土特产品有限公司 | Walnut oil soft capsule with antioxidation function and preparation method of same |
| CN103989177A (en) * | 2014-05-06 | 2014-08-20 | 宁波市成大机械研究所 | Deep sea fish oil soft capsule containing walnut kernel extract |
| CN106267106A (en) * | 2016-09-26 | 2017-01-04 | 宋妮 | Promote the compositions of memory improvement patients of senile dementia brain health status |
| CN111344000A (en) * | 2017-11-09 | 2020-06-26 | 雀巢产品有限公司 | Nutrient blends for animal health benefits |
| CN113546062A (en) * | 2021-08-05 | 2021-10-26 | 上海健康医学院 | Vitamin D soft capsule and preparation method thereof |
-
2008
- 2008-04-09 CN CN200810103633.XA patent/CN101253990A/en active Pending
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101485445B (en) * | 2009-02-23 | 2012-09-26 | 梁德昌 | Health care food |
| CN101618029B (en) * | 2009-07-19 | 2011-10-26 | 广东长兴科技保健品有限公司 | Soft capsule with function of improving memory and preparation technology thereof |
| CN102919842A (en) * | 2012-11-14 | 2013-02-13 | 汾州裕源土特产品有限公司 | Walnut oil soft capsule with antioxidation function and preparation method of same |
| CN103989177A (en) * | 2014-05-06 | 2014-08-20 | 宁波市成大机械研究所 | Deep sea fish oil soft capsule containing walnut kernel extract |
| CN106267106A (en) * | 2016-09-26 | 2017-01-04 | 宋妮 | Promote the compositions of memory improvement patients of senile dementia brain health status |
| CN111344000A (en) * | 2017-11-09 | 2020-06-26 | 雀巢产品有限公司 | Nutrient blends for animal health benefits |
| US11376297B2 (en) | 2017-11-09 | 2022-07-05 | Société des Produits Nestlé S.A. | Nutrition blend for health benefits in animals |
| US11648285B2 (en) | 2017-11-09 | 2023-05-16 | Société des Produits Nestlé S.A. | Nutrition blend for health benefits in animals |
| CN113546062A (en) * | 2021-08-05 | 2021-10-26 | 上海健康医学院 | Vitamin D soft capsule and preparation method thereof |
| CN113546062B (en) * | 2021-08-05 | 2022-11-01 | 上海健康医学院 | Vitamin D soft capsule and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101253990A (en) | Soft capsules improving memory function | |
| JP7007010B2 (en) | Lipid-containing composition and its usage | |
| CN102283386B (en) | Composite camellia oil health care product with function of reducing blood fat and preparation method thereof | |
| CN102204595B (en) | Functional edible oil containing lycoypene | |
| KR20060127865A (en) | Fat composition | |
| CN103431392B (en) | Composite marine food for special dietary uses for diabetics | |
| CN102318829B (en) | Compound camellia oil health product with function of blood pressure decreasing, and preparation method thereof | |
| CN102389115A (en) | Health food for alleviating visual fatigue and preparation method and application thereof | |
| CN101715913A (en) | Vivocon capsule and production process thereof | |
| CN103027300A (en) | VE (Vitamin E) coenzyme Q10 composition for assisting to reduce blood fat and boosting immunity and preparation method thereof | |
| CN102106411A (en) | Nutrient oil for diabetics | |
| CN101999649B (en) | Antioxidant health-care product composition and preparation method thereof | |
| CN101878914A (en) | Seabuckthorn compound oil combined health care products and preparation method thereof | |
| JP6450317B2 (en) | Soft capsule containing DHA and EPA | |
| CN105707291A (en) | Camellia blend oil suitable for wet nurse | |
| CN106420659B (en) | A kind of bean-containing capsule and preparation method thereof | |
| CN106418542A (en) | Health-care product having function of regulating blood lipids and preparation method thereof | |
| CN101194913A (en) | Natural seal oil compression biological preparation for treating hyperlipidemia and technique of preparing the same | |
| CN102106534A (en) | Composition for assisting in lowering blood fat and preparation method thereof | |
| CN102763845A (en) | Seabuckthorn fruit oil and propolis soft capsule | |
| CN103462038B (en) | Propolis corn-oil softgel and preparation method thereof | |
| Ulbricht | An evidence-based systematic review of lutein by the Natural Standard Research Collaboration | |
| CN102511825B (en) | Functional health microcapsule of turtle oil and for blood fat reduction and preparation method thereof | |
| CN106858242B (en) | Walnut kernel liposome beverage and preparation method thereof | |
| CN100544711C (en) | A kind of formulation product of prevention of prostatic hyperplasia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20080903 |